BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30657340)

  • 1. Prescribing in 2019: what are the safety concerns?
    Coleman JJ
    Expert Opin Drug Saf; 2019 Feb; 18(2):69-74. PubMed ID: 30657340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review.
    Sawan M; Reeve E; Turner J; Todd A; Steinman MA; Petrovic M; Gnjidic D
    Expert Rev Clin Pharmacol; 2020 Mar; 13(3):233-245. PubMed ID: 32056451
    [No Abstract]   [Full Text] [Related]  

  • 3. Prescribing issues in elderly individuals living with HIV.
    Marzolini C; Livio F
    Expert Rev Clin Pharmacol; 2019 Jul; 12(7):643-659. PubMed ID: 31155978
    [No Abstract]   [Full Text] [Related]  

  • 4. [Need for improvement in education on appropriate prescribing in elderly patients].
    Keijsers CJ; Jansen PA; Brouwers JR; de Wildt DJ
    Ned Tijdschr Geneeskd; 2015; 159():A9609. PubMed ID: 26732217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving optimal prescribing: what can physicians do?
    Shortt S; Sketris I
    Can Fam Physician; 2012 Aug; 58(8):820-1. PubMed ID: 22893327
    [No Abstract]   [Full Text] [Related]  

  • 6. Methods to control the pharmaceutical cost impact of chronic conditions in the elderly.
    Vivas-Consuelo D; Usó-Talamantes R; Trillo-Mata JL; Mendez-Valera P
    Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):425-37. PubMed ID: 25703585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.
    Reeve E; Moriarty F; Nahas R; Turner JP; Kouladjian O'Donnell L; Hilmer SN
    Expert Opin Drug Saf; 2018 Jan; 17(1):39-49. PubMed ID: 29072544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Licence to Prescribe.
    Kramers C; Janssen BJ; Knol W; Hessel MHM; Mulder WM; Dumont G; Maassen van den Brink A; Tichelaar J
    Br J Clin Pharmacol; 2017 Aug; 83(8):1860-1861. PubMed ID: 28256012
    [No Abstract]   [Full Text] [Related]  

  • 9. The Fit fOR The Aged (FORTA) project and its clinical implications.
    Pazan F; Wehling M
    Expert Opin Drug Metab Toxicol; 2020 Apr; 16(4):275-277. PubMed ID: 32163717
    [No Abstract]   [Full Text] [Related]  

  • 10. Classic challenges and emerging approaches to medication therapy in older adults.
    Alagiakrishnan K; Mah D; Padwal R
    Discov Med; 2018 Oct; 26(143):137-146. PubMed ID: 30586537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deprescribing medications in older people: a narrative review.
    Salahudeen MS
    Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Swimming Against the Tide: Primary Care Physicians' Views on Deprescribing in Everyday Practice.
    Wallis KA; Andrews A; Henderson M
    Ann Fam Med; 2017 Jul; 15(4):341-346. PubMed ID: 28694270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prioritizing interventions to manage polypharmacy in Australian aged care facilities.
    Jokanovic N; Wang KN; Dooley MJ; Lalic S; Tan EC; Kirkpatrick CM; Bell JS
    Res Social Adm Pharm; 2017; 13(3):564-574. PubMed ID: 27374998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is my older cancer patient on too many medications?
    Turner JP; Shakib S; Bell JS
    J Geriatr Oncol; 2017 Mar; 8(2):77-81. PubMed ID: 27840102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical consequences of polypharmacy in elderly.
    Maher RL; Hanlon J; Hajjar ER
    Expert Opin Drug Saf; 2014 Jan; 13(1):57-65. PubMed ID: 24073682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypharmacy and deprescribing: just ask the patient.
    Cave JA
    Drug Ther Bull; 2020 Jan; 58(1):2. PubMed ID: 31727779
    [No Abstract]   [Full Text] [Related]  

  • 17. Bundle interventions used to reduce prescribing and administration errors in hospitalized children: a systematic review.
    Bannan DF; Tully MP
    J Clin Pharm Ther; 2016 Jun; 41(3):246-55. PubMed ID: 27145467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of the prevalence and incidence of prescribing errors with high-risk medicines in hospitals.
    Alanazi MA; Tully MP; Lewis PJ
    J Clin Pharm Ther; 2016 Jun; 41(3):239-45. PubMed ID: 27167088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing medication burden and polypharmacy: finding the perfect measure.
    Gnjidic D; Tinetti M; Allore HG
    Expert Rev Clin Pharmacol; 2017 Apr; 10(4):345-347. PubMed ID: 28271722
    [No Abstract]   [Full Text] [Related]  

  • 20. Reducing inappropriate polypharmacy: the process of deprescribing.
    Scott IA; Hilmer SN; Reeve E; Potter K; Le Couteur D; Rigby D; Gnjidic D; Del Mar CB; Roughead EE; Page A; Jansen J; Martin JH
    JAMA Intern Med; 2015 May; 175(5):827-34. PubMed ID: 25798731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.